The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling

详细信息    查看全文

• 作者：Wei Chen (1)
  Qiang Gao (2)
  Siqi Han (3)
  Fei Pan (4)
  Wei Fan (5)
  
  1. Department of Respiratory ; Navy General Hospital ; Beijing ; 100048 ; China
  2. Department of Geriatrics ; Second Affiliated Hospital of Harbin Medical University ; Haerbin ; 150086 ; China
  3. Department of Medical Oncology ; Jinling Hospital ; Nanjing ; 210002 ; China
  4. Department of Gastroenterology and Hepatology ; Chinese PLA General Hospital ; Beijing ; 100853 ; China
  5. Department of Anesthesiology ; Huai鈥檃n First People鈥檚 Hospital ; Nanjing Medical University ; 6 Beijing Road West ; Huai鈥檃n ; 223300 ; China
  
• 关键词：IL ; 6 ; CCL2 ; Coaction ; Epithelial ; mesenchymal transition ; Tumor microenvironment ; Metastasis
• 刊名：Tumor Biology
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：36
• 期：2
• 页码：973-981
• 全文大小：1,599 KB
• 参考文献：1. Onder, TT, Gupta, PB, Mani, SA, Yang, J, Lander, ES, Weinberg, RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: pp. 3645-54 58/0008-5472.CAN-07-2938" target="_blank" title="It opens in new window">CrossRef
  2. Polyak, K, Weinberg, RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: pp. 265-73 CrossRef
  3. Neel, DS, Bivona, TG (2013) Secrets of drug resistance in NSCLC exposed by new molecular definition of EMT. Clin Cancer Res 19: pp. 3-5 58/1078-0432.CCR-12-3232" target="_blank" title="It opens in new window">CrossRef
  4. Thiery, JP, Acloque, H, Huang, RY, Nieto, MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: pp. 871-90 CrossRef
  5. Soltermann, A, Tischler, V, Arbogast, S, Braun, J, Probst-Hensch, N, Weder, W (2008) Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14: pp. 7430-7 58/1078-0432.CCR-08-0935" target="_blank" title="It opens in new window">CrossRef
  6. Thomson, S, Petti, F, Sujka-Kwok, I, Mercado, P, Bean, J, Monaghan, M (2011) A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28: pp. 137-55 585-010-9367-3" target="_blank" title="It opens in new window">CrossRef
  7. Wu, Y, Deng, J, Rychahou, PG, Qiu, S, Evers, BM, Zhou, BP (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15: pp. 416-28 CrossRef
  8. Kang, Y, Massague, J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118: pp. 277-9 CrossRef
  9. Sabbah, M, Emami, S, Redeuilh, G, Julien, S, Prevost, G, Zimber, A (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11: pp. 123-51 CrossRef
  10. Moustakas, A, Heldin, CH (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: pp. 1512-20 550.x" target="_blank" title="It opens in new window">CrossRef
  11. Scheel, C, Eaton, EN, Li, SH, Chaffer, CL, Reinhardt, F, Kah, KJ (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: pp. 926-40 CrossRef
  12. Sullivan, NJ, Sasser, AK, Axel, AE, Vesuna, F, Raman, V, Ramirez, N (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28: pp. 2940-7 CrossRef
  13. Gonzalez-Moreno, O, Lecanda, J, Green, JE, Segura, V, Catena, R, Serrano, D (2010) VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Exp Cell Res 316: pp. 554-67 CrossRef
  14. Zavadil, J, Bottinger, EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: pp. 5764-74 CrossRef
  15. Heldin, CH, Landstrom, M, Moustakas, A (2009) Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21: pp. 166-76 CrossRef
  16. Rose-John, S, Waetzig, GH, Scheller, J, Grotzinger, J, Seegert, D (2007) The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11: pp. 613-24 517/14728222.11.5.613" target="_blank" title="It opens in new window">CrossRef
  17. Rokavec, M, Wu, W, Luo, JL (2012) IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell 45: pp. 777-89 5" target="_blank" title="It opens in new window">CrossRef
  18. Chang, CH, Hsiao, CF, Yeh, YM, Chang, GC, Tsai, YH, Chen, YM (2013) Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. Int J Cancer 132: pp. 1977-85 CrossRef
  19. Zhao, Z, Cheng, X, Wang, Y, Han, R, Li, L, Xiang, T (2014) Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. PLoS One 9: pp. e95884 5884" target="_blank" title="It opens in new window">CrossRef
  20. Yadav, A, Kumar, B, Datta, J, Teknos, TN, Kumar, P (2011) IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9: pp. 1658-67 58/1541-7786.MCR-11-0271" target="_blank" title="It opens in new window">CrossRef
  21. Schweizer, A, Dejager, S, Bosi, E (2009) Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabetes Obes Metab 11: pp. 804-12 51.x" target="_blank" title="It opens in new window">CrossRef
  22. Kudo-Saito, C, Shirako, H, Ohike, M, Tsukamoto, N, Kawakami, Y (2013) CCL2 is critical for immunosuppression to promote cancer metastasis. Clin Exp Metastasis 30: pp. 393-405 585-012-9545-6" target="_blank" title="It opens in new window">CrossRef
  23. Izumi, K, Fang, LY, Mizokami, A, Namiki, M, Li, L, Lin, WJ (2013) Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med 5: pp. 1383-401 CrossRef
  24. Albini, A, Magnani, E, Noonan, DM (2010) The tumor microenvironment: biology of a complex cellular and tissue society. Q J Nucl Med Mol Imaging 54: pp. 244-8
  25. Chaffer, CL, Weinberg, RA (2011) A perspective on cancer cell metastasis. Science 331: pp. 1559-64 543" target="_blank" title="It opens in new window">CrossRef
  26. Grivennikov, SI, Karin, M (2011) Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 70: pp. i104-8 5" target="_blank" title="It opens in new window">CrossRef
  27. Yu, H, Pardoll, D, Jove, R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: pp. 798-809 CrossRef
  28. Zhang, XW, Qin, X, Qin, CY, Yin, YL, Chen, Y, Zhu, HL (2013) Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance. Cancer Immunol Immunother 62: pp. 563-70 CrossRef
  29. Lu, Y, Cai, Z, Xiao, G, Liu, Y, Keller, ET, Yao, Z (2007) CCR2 expression correlates with prostate cancer progression. J Cell Biochem 101: pp. 676-85 CrossRef
  30. Salcedo, R, Ponce, ML, Young, HA, Wasserman, K, Ward, JM, Kleinman, HK (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: pp. 34-40
  31. Lu, X, Kang, Y (2009) Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem 284: pp. 29087-96 5899" target="_blank" title="It opens in new window">CrossRef
  32. Zhou, C, Liu, J, Tang, Y, Liang, X (2012) Inflammation linking EMT and cancer stem cells. Oral Oncol 48: pp. 1068-75 5" target="_blank" title="It opens in new window">CrossRef
  33. Low-Marchelli, JM, Ardi, VC, Vizcarra, EA, Rooijen, N, Quigley, JP, Yang, J (2013) Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res 73: pp. 662-71 58/0008-5472.CAN-12-0653" target="_blank" title="It opens in new window">CrossRef
  34. Cheng, GZ, Zhang, WZ, Sun, M, Wang, Q, Coppola, D, Mansour, M (2008) Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 283: pp. 14665-73 CrossRef
  
• 刊物主题：Cancer Research;
• 出版者：Springer Netherlands
• ISSN：1423-0380

文摘

The pattern of secreted factors in the tumor microenvironment has been shown to initiate tumor epithelial-mesenchymal transition (EMT); however, little is known about their interplay undergoing this phenotypic switch. In this study, we revealed obvious coactions of cytokine IL-6 and chemokine CCL2 during EMT induction. We found that IL-6 effectively induced EMT and promoted tumor cell invasion, which could be markedly enhanced by addition of CCL2 in a CCR2-dependent manner. IL-6 and CCL2 induced each other and cooperatively elicited STAT3 phosphorylation; conversely, STAT3 regulated the production of IL-6 and CCL2, thus constituting a positive feedback loop to maintain and amplify STAT3 signaling, consequently promoting additional EMT events. Furthermore, CCL2 greatly enhanced IL-6-induced EMT events mainly by upregulating the expression of Twist. Genetic or pharmacological inhibition of STAT3 disrupted STAT3-centered loop and markedly suppressed Twist expression as well as IL-6/CCL2-mediated EMT induction. Thus, our findings highlighted the synergy of the two secreted factors of tumor microenvironment, in regulating transformed properties of non-small cell lung cancer (NSCLC).